| disease |
Chronic Sulfur Mustard Exposure |
--- |
| paper link |
https://pubmed.ncbi.nlm.nih.gov/27079636
|
--- |
| reference vancouver |
Panahi Y, Ghanei M, Vahedi E, Mousavi SH, Imani S, Sahebkar A. Efficacy of probiotic supplementation on quality of life and pulmonary symptoms due to sulfur mustard exposure: a randomized double-blind placebo-controlled trial. Drug and chemical toxicology. 2016:1-6 |
--- |
| type of study |
in vivo |
--- |
| info_type_of_study |
- |
--- |
| organism |
Homo sapiens |
--- |
| info_organism |
SM-exposured patients with probiotics treatment |
--- |
| sample type |
NM |
--- |
| info_sample_type |
- |
--- |
| variable_name |
- |
--- |
| official symbol |
maximal mid-expiratory flow |
See FEF25–75; mid‑expiratory flow used to evaluate small airway function. |
| info official symbol |
- |
--- |
| variable category |
Phenotype |
--- |
| sign of difference id |
NC |
--- |
| experimental design id |
Randomized double-blind clinical trial |
--- |
| case |
Chronic Sulfur Mustard Exposure |
--- |
| info case |
SM-patients with probiotic treatment for 6 weeks |
--- |
| case count |
40 |
--- |
| control |
Placebo |
--- |
| info_control |
- |
--- |
| control count |
20 |
--- |
| technique |
NM |
--- |
| p value |
=0.063 |
--- |
| confidence interval |
NM |
--- |
| year of publication |
2016 |
--- |
| correspond name |
Mostafa Ghanei |
--- |
| email |
mghaneister@gmail.com |
--- |
